NovaBay Pharmaceuticals, Inc.
NBY
$1.02
$0.088.50%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.24M | 3.32M | 3.66M | -7.22M | -10.12M |
| Total Depreciation and Amortization | 223.00K | 280.00K | 332.00K | 373.00K | 373.00K |
| Total Amortization of Deferred Charges | 87.00K | 194.00K | 485.00K | 874.00K | 1.44M |
| Total Other Non-Cash Items | 664.00K | 334.00K | 952.00K | 2.02M | 4.44M |
| Change in Net Operating Assets | -193.00K | -370.00K | 701.00K | -367.00K | -306.00K |
| Cash from Operations | 4.02M | 3.76M | 6.13M | -4.32M | -4.17M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -2.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -2.00K | -5.00K |
| Total Debt Issued | 500.00K | 500.00K | 500.00K | 500.00K | 0.00 |
| Total Debt Repaid | -1.03M | -1.30M | -1.92M | -1.99M | -2.70M |
| Issuance of Common Stock | 851.00K | 3.49M | 3.72M | 3.11M | 3.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 3.79M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.82M | -- | -- | -- | -- |
| Other Financing Activities | -1.99M | -1.99M | -1.91M | -115.00K | -2.00K |
| Cash from Financing | -2.70M | 706.00K | 388.00K | 1.50M | 973.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 126.00K | 126.00K | 126.00K | 126.00K | 590.00K |
| Net Change in Cash | 1.45M | 4.59M | 6.65M | -2.70M | -2.61M |